. The corresponding differential equations can be found in the simulation files for each model. All chosen model structures only deal with the essential dynamics, and are no attempts to include all known reactions or components of the system. Simulated results are depicted as blue solid lines (one line for each extreme acceptable parameter-set), and experimental data are depicted as red, filled circles with error-bars (± one SE). A) IR phosphorylation in response to 100 nM insulin. Experimental data from isolated adipocytes. B) IRS1 phosphorylation in response to 100 nM insulin. Experimental data from isolated adipocytes. C) IRS1 phosphorylation in response to first 1.2 nM at 0 min, and then 10 nM insulin at 4 min. Experimental data from isolated adipocytes. D) IRS1 phosphorylation in response to 10 nM insulin.
Experimental data from isolated adipocytes. E) Dose-response for glucose uptake in response to increasing concentrations of insulin. Experimental data from isolated adipocytes. F) Glucose uptake by the adipose tissue in response to a meal. Experimental data from the Dalla Man-model. Experimental data from isolated adipocytes. E) Dose-response for glucose uptake in response to increasing concentrations of insulin. Experimental data from isolated adipocytes. F) Glucose uptake by the adipose tissue in response to a meal. Experimental data from the Dalla Man-model.
TABLE S1
Model rejections for different degrees of freedom and levels of significance 
Supplemental Tables S1-S2 Level of significance 1% 5% 5% 5%
Basal GLUT4 translocation hypothesis
Supplemental Methods

Principles of constructing and simulating a model using module constraints
Consider model structure Ma1 in Figure S1 . We assume that all reactions follow mass action kinetics and act through simple multiplication. We also assume that the basal activation is given by a basal activation of the insulin receptor. With these assumption, the set of differential equations become
The total amounts of the proteins are unknown and we thus use relative amounts to describe the initial Recall that all chosen models only deal with the essential dynamics, and are no attempts to include all known reactions and components of the system.
All model equations are found in the supplemental file ModelFiles.zip and all simulations of the models are found in the supplemental file SimulationFiles.zip.
Supplemental Description of Model
The final model M 3 consists of three levels: whole-body level, adipose tissue level, and insulin binding level. A schematic overview of the system is found below. Here we present the model equations for all these levels and show how we merge the levels into one multi-level model. The connections between the whole-body level and the other levels are in red, and connections between the adipose tissue level and the insulin binding level in green.
The whole-body level
The whole-body level is taken from (3) with one small modification. We sub-divided the insulinresponding glucose uptake module in two parts; muscle and adipose tissue, with static 80/20 proportions. We did not change the values of the parameters. A schematic overview of the whole-body level is given by the following figure.
Glucose kinetics The glucose kinetics module describes the dynamic change in glucose concentration in the two compartments plasma and tissues. More motivations for these equations are given in (3). The same holds for all equations relating to the whole-body level. Glucose Uptake The glucose uptake by the insulin sensitive tissues is a sum of glucose uptake in muscle and adipose tissue. Recall that we mark a connection between the whole-body level and the other levels with red.
U_id = U_idm+vglucoseuptake
U_id insulin dependent glucose uptake Glucose Uptake (muscle tissue) Glucose is taken up in the muscle tissue and the uptake depends on the interstitial insulin and the glucose tissue concentrations. helping state to calculate the insulin secretion S insulin secretion to beta cells S_po insulin secretion to the portal vein Glucose Renal Excretion When the concentration of glucose in the blood is high glucose will be excreted to the kidneys. However, this will not happen for healthy individuals so we set the renal excretion to 0.
Parameters
We use the parameters that have been determined and further described in (3 
The adipose tissue level
The adipose tissue level is developed by us in this study. We have tested a number of hypotheses to find a minimal model (Md3), partly based on (2) , that can explain all our experimental data and fit the module constraints from the whole-body level. This hypothesis we have then expanded to include interesting proteins within the adipocyte. The parameters of this level were optimized to gather all the acceptable parameter sets. A schematic overview of the adipose tissue level is the following figure. IRS1 and X dynamics The insulin receptor substrate is activated by phosphorylation from active insulin receptor states from the insulin binding level described below. Also, positive feedbacks from downstream proteins further activate IRS1. The unknown protein X is activated by IRS1iP and act as a negative feedback to the insulin receptor. This part of the adipose tissue level is adopted from and further described in (2), with the difference that we have now replaced the insulin receptor states with corresponding ones from the insulin binding level. Recall that we mark connections between the adipose tissue level and the insulin binding level with green.
IRS1(0) = 9.99982 IRS1iP(0) = 0.00018 X(0) = 9.92463 X_P(0) = 0.07537 v2f = k21*IRS1*((r1x2+r11x2+r1x22+r1x22d+r11x22+rPbasal)+k22*rendP) *(1+k23*PKC_P+k24*mTOR) v2b = k2b*IRS1iP v3f = k3f*X*IRS1iP v3b = k3b*X_P
IRS1
insulin receptor substrate-1 IRS1iP phosphorylated (active) form of IRS1 X downstream intermediate which dephosphorylates IR in its active form X_P active form of X PI3K and PDK1 dynamics PI3K is activated by IRS1 and subsequently PDK1 is activated by PI3K. We assume that the activations follow simple mass-action kinetics.
PI3K(0) = 9.97578 PI3K_(0) = 0.02422 PDK1(0) = 8.65877 PDK1_(0) = 1.34123 v4f = k4f*PI3K*IRS1iP v4b = k4b*PI3K_ v5f = k5f*PDK1*PI3K_ v5b = k5b*PDK1_ PI3K phosphatidylinositol 3-kinases PI3K_ active form of PI3K PDK1 3-phosphoinositide dependent protein kinase-1 PDK1_ active form of PDK1 PKC and PKB dynamics Both PKB and PKC are activated by PDK1 in its active form. We assume that the activations follow simple mass-action kinetics.
PKC(0) = 3.60284e-05 PKC_P(0) = 9.99996 PKB(0) = 9.90193 PKB_P(0) = 0.09807 v6f = k6f*PKC*PDK1_ v6b = k6b*PKC_P v7f = k7f*PKB*PDK1_ v7b = k7b*PKB_P PKC protein kinase C PKC_P phosphorylated (active) form of PKC PKB protein kinase B PKB_P phosphorylated (active) form of PKB mTOR and GLUT4 dynamics mTOR is activated by PKB in its active form. The glucose transporters (GLUT4) are moving from the cytosol to the plasma membrane both at a basal level and when activated by PKB and PKC. We assume that the activations follow simple mass-action kinetics.
mTOR(0) = 0.02019 mTOR_(0) = 9.97981 GLUT4_C(0) = 9.99317 GLUT4_M(0) = 0.00683 v8f = k8f*mTOR*PKB_P v8b = k8b*mTOR_ v9f = k91*GLUT4_C*PKC_P+k92*GLUT4_C*PKB_P+k5BasicWb*GLUT4_C v9b = k9b*GLUT4_M mTOR mammalian target of rapamycin mTOR_ active form of mTOR GLUT4_C glucose transporter 4 in vesicles in the cytosol GLUT4_M glucose transporter 4 in the plasma membrane ready to take up glucose Glucose uptake dynamics The glucose uptake in the adipose tissue comes in this model from three terms; glucose transporter 1 (noninsulin dependent), glucose transporter 4 (insulin-dependent through the insulin signaling cascade and thus through GLUT4), and blood flow (directly insulin-dependent). We assume that the glucose uptake also depends on the interstitial glucose concentration (G_t, from the whole-body level) and that the dependency is saturated. vglucoseuptake = k_glut1*G_t/(KmG1+G_t)+k_glut4*GLUT4_M*G_t/(KmG4+G_t)+kbf*(INS+5)
Parameters
The parameters of the adipose tissue level were optimized to find the acceptable solutions. The following parameters are part of this level .   k21  k22  k23  k24  k2b  k3f  k3b  k4f  k4b  k5f  k5b  k6f  k6b  k7f  k7b  k8f  k8b  k91  k92 k9b k5Basic k5BasicWb k_glut4 k_glut1 KmG1 KmG4 kbf
The insulin binding level
The insulin binding level is taken from (4) . We took the model structure and merged with our adipose tissue module. The parameters in (4) were fitted to data from other cell types so we used optimization to gather the acceptable parameter sets. A schematic overview of the insulin binding level is found below.
The inactive receptor states The following insulin receptor states can bind one or two insulin molecules, or be unbound. The states that bind at least one insulin molecule can be activated. The active receptor states When insulin is bound to the receptor it can be activated and also phosphorylated. The active states activate IRS1 at the adipose tissue level (above).
r1x2(0) = 1.36476e-06 r11x2(0) = 1.51514e-09 r1x22(0) = 6.39352e-010 r1x22d(0) = 5.59231e-020 r11x22(0) = 1.78726e-014 r1x2 active receptor state with 2 insulin molecules bound to site 1 and 2 respectively r11x2 active receptor state with 3 insulin molecules bound, 2 to site 1 and 1 to site 2 r1x22 active receptor state with 3 insulin molecules bound, 1 to site 1 and 2 to site 2 r1x22d active receptor state with 1 insulin molecules bound to site 1 and an insulin dimer to site 2 r11x22 active receptor state with 4 insulin molecules bound, 2 to site 1 and 2 to site 2
The internalization process We included internalization in the insulin binding model to be able to relate the insulin binding level with the adipose tissue level. This part is based the Mifa model in (2) . R1 = 2*a1*S1*r0 R2 = 2*a2*S1*r0 R3 = a1*S1*r1 R4 = a1*S1*r2 R5 = d1*r1 R6 = a2*S1*r1 R7 = a2*S1*r2 R8 = d2*r2 R9 = Kcr*r1 R10 = Kcr*r2 R11 = a1*S1*r1x2 R12 = 2*d1*r11 R13 = d1*r12 R14 = a2*S1*r1x2 R15 = d2*r12 R16 = 2*d2*r22 R17 = 2*Kcr*r11 R18 = Kcr*r12 R19 = d2*r1x2 R20 = Kcr*r12 R21 = 2*Kcr*r22 R22 = d1*r1x2 R23 = a2*S2*r1x2 R24 = d1*r11x2 R25 = d2*r1x22 R26 = d2*r11x2 R27 = d2*r1x22 R28 = d1*r11x2 R29 = d1*r1x22 R30 = a1*S1*r1x22 R31 = a2*S1*r11x2 R32 = K4*S1*r1x22 R33 = K8*r1x22d R34 = d2*r1x22d R35 = d1*r11x22 R36 = d2*r11x22 R37 = Kex*rend R38 = Kex*iend R39 = (Kend)*r1x2 R40 = (Kend)*r11x2 R41 = (Kend)*r1x22 R42 = (Kend)*r1x22d R43 = (Kend)*r11x22 R44 = (Kdp+Kcat*(X_P)/ (Km+(X_P)))*rendP R45 = (Kdp+Kcat*(X_P)/ (Km+(X_P)))*iendIR R46 = kfbasal*r0 R47 = krbasal*rPbasal R48 = Kend*rPbasal
Variables
The variables S1 and S2 describe the interstitial concentration of insulin as a monomer (S1) and as a dimer (S2) in molars. The dimer will not form in the low insulin concentrations in the physiological situation. S1 = (INS+5)*1e-12 S2 = 0 Parameters For two of the parameters, K4 and K8, we used the values from (4), and for the others we used optimization to find the acceptable values. 
